Angle plc signs new commercial agreement with AstraZeneca

LONDON: ANGLE plc (AIM:AGL), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology has signed a supplier agreement with the global biopharmaceutical company, AstraZeneca PLC, to develop and validate a methodology leveraging ANGLE’s existing DNA damage response (“DDR”) assay for the detection of…

ELOP enters into commercial agreement with Endur

OSLO: ELOP and Endur AAK have entered into a cooperation agreement for the use and delivery of ELOP’s technology. The agreement enables AAK to offer unique inspections services based on ELOP’s patented technology. ENDÚR AAK, has market-leading expertise in access technology and services such as inspection, repair and maintenance of, among other things, concrete structures.…

Directa Plus signs technical and commercial agreement with Italdesign

LONDON: Directa Plus, a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, has signed a technical and commercial agreement with Italdesign S.p.A, a global leader in automotive design and engineering, a news release said. Part of Volkswagen AG, Italdesign also specialises in styling, engineering, prototyping and testing…